📰 Abt News
Page 159 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
May 5, 2023
Crewe Advisors LLC trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 6.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,943 shares of the healthcare product maker’s stock after selling 139 shares during the […]
May 5, 2023
Donoghue Forlines LLC lifted its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 101.8% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 9,177 shares of the healthcare product maker’s stock after buying an additional 4,630 shares during the period. Donoghue Forlines LLC’s holdings in […]
May 5, 2023
Glenview Trust Co raised its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.5% during the 4th quarter, Holdings Channel reports. The fund owned 84,449 shares of the healthcare product maker’s stock after purchasing an additional 455 shares during the period. Glenview Trust Co’s holdings in Abbott Laboratories were worth $9,272,000 at […]
May 5, 2023
River Street Advisors LLC purchased a new stake in Abbott Laboratories (NYSE:ABT – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 5,449 shares of the healthcare product maker’s stock, valued at approximately $598,000. A number of other institutional investors have also modified their holdings […]
May 5, 2023
California Public Employees Retirement System decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,912,104 shares of the healthcare product maker’s stock after selling 102,575 shares during the […]
May 5, 2023
Richwood Investment Advisors LLC decreased its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,232 shares of the healthcare product maker’s stock after selling 544 shares during the quarter. Richwood […]
May 5, 2023
Stewart Asset Management LLC reduced its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 6.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 46,297 shares of the healthcare product maker’s stock after selling 3,384 shares during the quarter. Abbott Laboratories […]
May 5, 2023
Sivik Global Healthcare LLC boosted its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 50.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 45,000 shares of the healthcare product maker’s stock after purchasing an additional 15,000 shares during the quarter. Abbott Laboratories makes […]
May 4, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) EVP Andrea F. Wainer sold 8,226 shares of the stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $110.56, for a total value of $909,466.56. Following the sale, the executive vice president now owns 70,427 shares in the company, valued at […]
May 4, 2023
McKinley Carter Wealth Services Inc. lowered its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 33.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,612 shares of the healthcare product maker’s stock after selling 5,405 shares during the quarter. McKinley Carter […]